Contineum Therapeutics (CTNM) Beats Q2 Earnings Estimates by $0.05
Earnings Results Contineum Therapeutics (NASDAQ:CTNM) reported quarterly earnings results on July 30, 2026 that exceeded analyst expectations. The Healthcare company reported…
Read more
